Lilly’s Synthetic Molecule Design and Development (SMDD) organization develops active pharmaceutical ingredients and formulated drug products from preclinical development through commercialization, spanning small molecules, synthetic oligonucleotides, and synthetic peptides. The Crystallization Process Development Engineer will join the Crystallization Science team at a new development facility in Indianapolis and lead crystallization work across this diverse pipeline. The role collaborates closely with synthetic chemists, analytical scientists, formulation experts, and process engineers. The engineer leads crystallization process design from fundamental science—including nucleation kinetics, crystal growth, supersaturation control, solubility thermodynamics, and heat and mass transfer—to robust, scalable processes that provide clinical trial materials on time and to specification. The role applies cooling, antisolvent, reactive, and seeded crystallization strategies; process analytical technology (PAT); and Quality by Design (QbD) and Design of Experiments (DoE) methods to build process understanding and control. As a crystallization expert on integrated drug substance teams, the engineer guides particle engineering strategy, including particle size distribution, morphology, polymorphic form, and impurity rejection, and authors content for regulatory filings such as IND, IMPD, and NDA. The role also partners with formulation, analytical, and manufacturing teams, leads scale-up and technology transfer to pilot plants and external contract manufacturing organizations, mentors developing scientists, contributes to organizational standards and control strategies, and participates in external scientific activities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree